Trial site
Arizona Oncology Associates, PC - HOPE
- 5running trials
- 9closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer4 trials
- Triple-negative breast cancer3 trials
- Bladder cancer2 trials
- Head and neck cancer2 trials
- Lung cancer2 trials
- Melanoma2 trials
- Multiple myeloma2 trials
- Ovarian cancer2 trials
- Cervical cancer1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- and 3 more
- Phase
- Phase 37 trials
- Phase 25 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting5 trials
- Completed5 trials
- Terminated4 trials
- Lead sponsor
- Gilead Sciences3 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- Astellas Pharma Global Development, Inc.1 trial
- Bristol-Myers Squibb1 trial
- Hutchison Medipharma Limited1 trial
- and 6 more
Running trials
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma
Active, not recruiting
Active, not recruiting
Closed trials
Terminated
Terminated
Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma
Completed
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors
Completed
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer
Completed
Terminated
Completed
Completed
Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)
Terminated
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
Site data: ClinicalTrials.govUpdated 12 Nov 2026